SCHEMBL13638423

SCHEMBL13638423

C=C1CC(Nc2nccc(-c3ccc(N4CCNC(C)C4)s3)n2)CC(C)(C)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 9/20 0.37
CCND1 P24385 9/20 0.37
CCNA2 P20248 9/20 0.37
CDK2 P24941 9/20 0.37
CDK1 P06493 5/20 0.37
CCNB1 P14635 5/20 0.37
CCNA1 P78396 5/20 0.37
ZAP70 P43403 3/20 0.36
ROCK1 Q13464 2/20 0.35
CCNT1 O60563 5/20 0.34
CDK9 P50750 5/20 0.34
CCND3 P30281 4/20 0.34
CDK7 P50613 4/20 0.34
CCNH P51946 4/20 0.34
CDK6 Q00534 4/20 0.34
PRKD1 Q15139 2/20 0.32
PRKD2 Q9BZL6 2/20 0.32
ROCK2 O75116 1/20 0.31
IKBKB O14920 2/20 0.31
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638422 0.90 CDK9 (0.40) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL4481557 0.88 CDK4 (0.38) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638421 0.80 DGAT1 (0.44) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL14612785 0.79 IKBKB (0.37) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638454 0.79 CDK4 (0.36) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL3470774 0.78 CDK9 (0.40) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638286 0.77 ROCK2 (0.35) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638420 0.77 KDM4E (0.38) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638579 0.77 SRC (0.35) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL13638669 0.77 CDK2 (0.36) CDK4CCND1CCNA2CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed